Skip to main content

Table 2 Children’s health status and vaccination coverage in rural Andean Peru

From: A factorial cluster-randomised controlled trial combining home-environmental and early child development interventions to improve child health and development: rationale, trial design and baseline findings

 IHIP+IHIPECDControl
NMean (SD)
or % (N)
NMean (SD)
or % (N)
NMean (SD)
or % (N)
NMean (SD)
or % (N)
Anthropometricsa78 79 79 81 
 Height-for-age, Z-values64− 1.3 (1.1)50−1.0 (0.9)64−1.5 (1.1)61−1.4 (0.8)
 Stunting6417.2% (11)509.8% (5)6436.9% (24)6118.0% (11)
 Weight-for-age, Z-scores64−0.4 (1.0)51− 0.1 (0.8)65− 0.6 (0.9)61− 0.5 (0.9)
 Underweight646.3% (4)512.0% (1)6510.8% (7)614.9% (3)
Children’s health status78 79 79 81 
 Weight at birth 3.1 (0.6) 3 (0.5) 3.1 (0.5) 3.1 (0.4)
 Diarrhoea, two-weeks prevalence 18.4% (14) 22.8% (18) 19% (15) 26.3% (21)
 Fever, two-weeks prevalence 21.8% (17) 21.5% (17) 25.3% (20) 23.5% (19)
 Cough, two-weeks prevalence 35.1% (27) 31.7% (25) 39.2% (31) 29.1% (23)
 Children with no health coverage 10.3% (8) 10.1% (8) 5.1% (4) 1.2% (1)
Children’s vaccination78 79 79 81 
 Tuberculosis (BCG)7789.6% (69) 91.1% (72) 94.9% (75) 95.1% (77)
 Measles7750.7% (39)7860.3% (47)7767.5% (52) 64.2% (52)
 Diphtheria, convulsive cough and tetanus (DTP)b
  1st dose7796.1% (74) 94.9% (75) 98.7% (78) 95.1% (77)
  2nd dose7390.4% (66)7789.6% (69) 97.5% (77)7993.7% (74)
  3rd dose6487.5% (56)6979.7% (55)7293.1% (67)7382.2% (60)
 Polio (OPV)c        
  1st dose7796.1% (74) 96.2% (76) 98.7% (78) 96.3% (78)
  2nd dose7389.0% (65)7790.9% (70) 97.5% (77)7993.7% (74)
  3rd dose6478.1% (50)6979.7% (55)7290.3% (65)7375.3% (55)
 Influenza7762.3% (48) 63.3% (50) 81.0% (64) 69.1% (56)
 Hepatitis B7762.3% (48) 54.4% (43) 79.8% (63) 69.1% (56)
Recommended vaccines 6–11 months23 28 24 15 
 All vaccinesd 69.6% (16) 60.7% (17) 87.5% (21) 40% (6)
 No vaccines 0% (0) 7.1% (2) 0% (0) 0% (0)
Recommended vaccines 12–24 months41 41 48 58 
 All vaccinese 68.3% (28) 70.7% (29)4684.8% (39) 70.7% (41)
 No vaccines 2.4% (1) 4.9% (2) 2.1% (1) 0% (0)
Portable pulse oximetry assessmentf64 59 63 68 
 Oxygen saturation (SpO2) 93.5 (2.8) 94.2 (2.5) 93.8 (3.8) 93.8 (2.8)
 Respiratory rate per/min. 27.7 (3.7) 26.4 (3.0) 27.2 (2.7) 27.3 (3.1)
  1. 1As estimated on 15th December 2015 (±31 days). If several estimates within the range were available, the one closest to 15th of December was selected
  2. bDPT vaccination: 1st dose: 2 month; 2nd dose: 4 month; and 3rd dose: 6 month
  3. c Polio vaccination: 1st dose: 2 month; 2nd dose: 4 month; and 3rd dose: 6 month
  4. d It includes BCG (one dose), DTP (three doses) and OPV (three doses)
  5. e It includes BCG (one dose), DTP (three doses), OPV (three doses) and measles (one dose)
  6. f Results from children with no observable danger signs, fever, cough and difficulty to breath at the time of the assessment